(Q55313103)

English

Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926136

Prevention by chitosan of myelotoxicity, gastrointestinal toxicity and immunocompetent organic toxicity induced by 5-fluorouracil without loss of antitumor activity in mice. (English)

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926136

1 reference

based on heuristic

inferred from title

author name string

Y Kimura

1

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926136

H Okuda

2

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926136

publication date

1 July 1999

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926136

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Japanese Journal of Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926136

90

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926136

7

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926136

765-774

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926136

EXPERIMENTAL AND CLINICAL USE OF FLUORINATED PYRIMIDINES IN CANCER CHEMOTHERAPY.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

27 July 2018

Biomodulation of Fluorouracil in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

27 July 2018

Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

27 July 2018

Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

27 July 2018

Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

27 July 2018

Comparative immunotoxicity assessment of N4-Trimethoxybenzoyl-5'-deoxy-5- fluorocytidine (Ro 09-1390) and 5'-deoxy-5-fluorouridine (5'-DFUR) in BDF1 mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

27 July 2018

Antitumor activity of BOF-A2, a new 5-fluorouracil derivative.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

27 July 2018

Effects of the plasma concentration of 5-fluorouracil and the duration of continuous venous infusion of 5-fluorouracil with an inhibitor of 5-fluorouracil degradation on Yoshida sarcomas in rats.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

27 July 2018

Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

27 July 2018

Effect of uracil on metabolism of 5-fluorouracil in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

27 July 2018

Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

27 July 2018

Novel delivery systems for coagulation proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

12 August 2018

Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

12 August 2018

Rationale for treatment design: biochemical modulation of 5-fluorouracil by leucovorin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

12 August 2018

Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

12 August 2018

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5926136

12 August 2018

Effects of non-sugar fraction in black sugar on lipid and carbohydrate metabolism; Part I

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Metabolic characteristics and antitumor activity of BOF-A2, a new 5-fluorouracil derivative.]

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dietary fibers modulate indices of intestinal immune function in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphorus compounds in animal tissues; a comparison of methods for the estimation of nucleic acids

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide does not prevent diarrhea in patients treated with weekly 5-fluorouracil plus high-dose leucovorin

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Immunotoxic effects of a new antineoplastic agent S-1 in mice--comparison with S-1, UFT and 5-FU]

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term, ambulatory, continuous IV infusion of 5-FU for the treatment of advanced adenocarcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate in patients with advanced colorectal cancer. Results of a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preparation and evaluation of sustained release cross-linked chitosan microspheres containing phenobarbitone

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of geniposide isolated from Gardenia jasminoides on metabolic alterations in high sugar diet-fed rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic activity of oxaliplatin and 5-fluorouracil in patients with metastatic colorectal cancer with progressive disease while on or after 5-fluorouracil

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thymic humoral factor-gamma 2 (THF-gamma 2) immunotherapy reduces the metastatic load and restores immunocompetence in 3LL tumor-bearing mice receiving anticancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methotrexate loaded chitosan and chitin microspheres--in vitro characterization and pharmacokinetics in mice bearing Ehrlich ascites carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term weekly treatment of colorectal metastatic cancer with fluorouracil and leucovorin: results of a multicentric prospective trial of fluorouracil dosage optimization by pharmacokinetic monitoring in 152 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Antitumor activity and toxicity to the immune system and intestine, of the fluorinated pyrimidines FUra, 5'-DFUR, tegafur and UFT]

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of poly(vinyl alcohol)-gel spheres containing chitosan as dosage form to control gastrointestinal transit time of drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-FU infusion in advanced colorectal cancer: a comparison of three dose schedules

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The characteristics of the pathogenesis and immunomodulator treatment in the postoperative period in pseudophakia patients]

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo drug release and antitumor characteristics of water-soluble conjugates of mitomycin C with glycol-chitosan and N-succinyl-chitosan

1 reference

https://pubmed.ncbi.nlm.nih.gov/10470290

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1349-7006.1999.TB00813.X

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926136

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926136

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 July 2018

http://europepmc.org/abstract/PMC/5926136

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55313103&oldid=1962205529"